Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections The Medicines and Healthcare Products Regulatory Agency (MHRA) filing ...
Rezafungin is a next-generation, once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections, such as invasive candidiasis and candidemia The European ...
There are exceptions. In neonates or severely immunocompromised patients, candiduria may indicate disseminated candidiasis, which demands aggressive treatment. A patient who will shortly undergo a ...
SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing therapies designed to save lives and improve the standard of care for patients ...
The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...
CANDIDA infections linked to secukinumab were uncommon but often serious, with risk clustering early after treatment. Candida ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results